Breast ultrasound (sonography or ultrasonography) it is an important tool in the characterization of breast lesions, detected with mammography or clinical breast examination. However, a breast sonogram is not approved by the U.S. Food and Drug Administration (FDA) as a screening tool for breast cancer and is used additional to a mammogram.
Ultrasound is useful in guiding needles for fine needle aspiration and core biopsies. Breast ultrasound has optimal contrast resolution, but it lacks the spatial resolution of conventional mammography and cannot provide as much detail as a mammogram image. In addition, ultrasound is unable to show tiny calcium deposits (microcalcifications) that are often early indications of breast cancer.

See also Biopsy, Interventional Ultrasound, Ultrasound Safety, Side Effect and Ultrasound Regulations.

Echography (also called sonography) allows visualizing deep structures of the body by recording the reflections (echo) of ultrasound waves directed into the tissues. A medical diagnostic sonogram (echogram), as in echocardiography and echoencephalography, utilizes a frequency range of 1 to 10 MHz.

Imagent® is an injectable suspension for intravenous administration during a sonogram. This diagnostic contrast agent for enhancement of ultrasound images contains perflexane lipid microspheres. Imagent® US is indicated in the assessment of heart function and perfusion, as well as the detection of tumors and blood flow abnormalities by using gray scale, color Doppler, and harmonic ultrasound imaging techniques.
During the course of its development, the brand name for this product has changed from Imagent to Imavist (between August 2000 and March 2002) back to Imagent. The manufacturer's 06/03/02 press release announcing FDA approval refers to the product as 'Imagent (formerly Imavist),' and the approval notice and monograph posted at the FDA site refers to the product as Imagent.
Jointly developed by Alliance Pharmaceutical Corp and Bayer Schering Pharma AG (Germany). Source: PR Newswire - 10/10/96, 03/31/98, 10/13/99, 03/13/01, 10/08/01; FDA approvals - 05/31/02; Alliance Pharmaceutical press release - 06/03/02.
Currently the production of Imagent® is discontinued.

Ipsilateral describes a structure on the same side; for example in a sonogram of the left internal carotid artery, the ipsilateral common carotid artery would be the left common carotid artery.

Gynecologic ultrasound and obstetric ultrasound are two distinct applications of ultrasound imaging that serve different purposes in the field of women's health. While both involve the use of ultrasound technology to examine the pelvic region, they have different focuses and objectives.

Gynecologic [gynaecologic, Brit.] ultrasound primarily concentrates on the evaluation of the female reproductive organs, including the uterus, ovaries, fallopian tubes, and surrounding structures. It is commonly performed for various gynecological concerns, such as abnormal bleeding, pelvic pain, infertility investigations, and monitoring of reproductive disorders. It can identify signs of inflammation, the presence of free fluid, cysts, and tumors. This non-invasive technique aids in diagnosing and monitoring gynecological pathologies, facilitating early intervention and appropriate treatment. Typically, a transabdominal sonogram is performed with a full bladder to provide an initial assessment. However, if the pelvic ultrasound reveals any abnormalities or fails to provide a clear image of the organs, a more detailed evaluation can be achieved through a transvaginal sonography. This approach allows for improved visualization of the uterus and ovaries by placing the ultrasound probe inside the vagina.

Obstetric ultrasound, also known as prenatal, fetal or pregnancy ultrasound, is the branch of medical imaging that focuses on the use of ultrasound technology to assess the health and development of a fetus during pregnancy. Women with uncomplicated pregnancies commonly undergo an ultrasound examination between the 16th and 20th week of gestation. This routine assessment, performed with a real-time scanner, serves to determine accurate gestational age, monitor fetal size, and assess overall growth. The middle of the pregnancy trimester provides a crucial window for detecting many abnormalities of fetal anatomy. Advanced imaging techniques enable healthcare professionals to identify potential structural issues. Early detection of these abnormalities allows for timely intervention, counseling, and the implementation of appropriate management strategies.
See also Pregnancy Ultrasound, Pelvic Ultrasound, Hysterosalpingo Contrast Sonography and Vaginal Probe.